164 related articles for article (PubMed ID: 12385449)
1. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis.
Herrine SK; Michael B; Ma WL; Rossi S; Dunn SR; Hyslop T
Am J Gastroenterol; 2002 Oct; 97(10):2619-22. PubMed ID: 12385449
[TBL] [Abstract][Full Text] [Related]
2. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
3. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
[TBL] [Abstract][Full Text] [Related]
4. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
5. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.
Saab S; Martin P; Brezina M; Gitnick G; Yee HF
Am J Kidney Dis; 2001 Feb; 37(2):308-15. PubMed ID: 11157371
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
7. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
9. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
[TBL] [Abstract][Full Text] [Related]
10. Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients.
Milotic I; Pavic I; Maleta I; Troselj-Vukic B; Milotic F
Scand J Urol Nephrol; 2002; 36(6):447-9. PubMed ID: 12623510
[TBL] [Abstract][Full Text] [Related]
11. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral infection in a Chinese hemodialysis unit.
Li H; Wang SX
Chin Med J (Engl); 2010 Dec; 123(24):3574-7. PubMed ID: 22166633
[TBL] [Abstract][Full Text] [Related]
13. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
14. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
[TBL] [Abstract][Full Text] [Related]
15. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
[TBL] [Abstract][Full Text] [Related]
16. How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels.
Sookoian S; Castaño G; Frider B; Flichman D
Medicina (B Aires); 2002; 62(3):226-30. PubMed ID: 12150004
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program.
Lapane KL; Jakiche AF; Sugano D; Weng CS; Carey WD
Am J Gastroenterol; 1998 Apr; 93(4):591-6. PubMed ID: 9576453
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
Kaşifoğlu N; Us T; Akgün Y
Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
[TBL] [Abstract][Full Text] [Related]
19. Study of serum alanine-aminotransferase levels in blood donors in Spain.
Lozano M; Cid J; Bedini JL; Mazzara R; Gimenez N; Mas E; Ballesta A; Ordinas A
Haematologica; 1998 Mar; 83(3):237-9. PubMed ID: 9573678
[TBL] [Abstract][Full Text] [Related]
20. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B.
Hung KY; Lee KC; Yen CJ; Wu KD; Tsai TJ; Chen WY
Nephrol Dial Transplant; 1997 Jan; 12(1):180-3. PubMed ID: 9157333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
